Lunai Bioworks (LNAI) Other Operating Expenses (2013 - 2026)
Lunai Bioworks (LNAI) posted quarterly Other Operating Expenses of -$1.4 million for Q1 2026, up 66.36% year-over-year from -$847695.0 in Q1 2025, and up 19.64% quarter-over-quarter from -$1.8 million in Q4 2025.
Lunai Bioworks (LNAI) Other Operating Expenses (2013 - 2026) Analysis & Trends
Lunai Bioworks' Other Operating Expenses history runs 14 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 66.36% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at $114.1 million (up 124.65% YoY), while the FY2025 annual figure was $152.7 million, up 412.05% from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$1.4 million, up from -$1.8 million in the prior quarter.
- The five-year high for Other Operating Expenses was $118.8 million in Q2 2025, with the low at -$4.3 million in Q4 2024.
- The 5-year median for Other Operating Expenses is $28401.0 (2022), against an average of $18.6 million.
- Peak annual rise in Other Operating Expenses reached 174687.65% in 2024, while the deepest fall reached 13130.02% in 2024.
- Lunai Bioworks' Other Operating Expenses stood at $28844.0 in 2022, then increased by 14.97% to $33162.0 in 2023, then tumbled by 13130.02% to -$4.3 million in 2024, then soared by 59.39% to -$1.8 million in 2025, then increased by 19.64% to -$1.4 million in 2026.
- Business Quant data shows LNAI's Other Operating Expenses at -$1.4 million in Q1 2026, -$1.8 million in Q4 2025, and -$1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.41 Mn |
| Dec 31, 2025 | -1.75 Mn |
| Sep 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | 118.84 Mn |
| Mar 31, 2025 | -4.19 Mn |
| Dec 31, 2024 | -4.32 Mn |
| Sep 30, 2024 | 47.65 Mn |
| Jun 30, 2024 | 11.67 Mn |
| Mar 31, 2024 | 42.64 Mn |
| Dec 31, 2023 | 33,162.00 |
| Sep 30, 2023 | 27,260.00 |
| Jun 30, 2023 | 18.99 Mn |
| Mar 31, 2023 | 28,242.00 |
| Dec 31, 2022 | 28,844.00 |
| Sep 30, 2022 | 28,401.00 |
| Jun 30, 2022 | 93.28 Mn |
| Mar 31, 2022 | -4.00 Mn |
| Dec 31, 2021 | -161,332.00 |
| Sep 30, 2021 | -17,459.00 |
| Jun 30, 2021 | 9.07 Mn |